Implant for Chronic Eye Disorder Wins FDA Approval

Published on October 22, 2021

The U.S. Food and Drug Administration on Friday approved Swiss drugmaker Roche Holding AG’s eye implant for a chronic disorder causing blurred vision, most patients of whom currently have to receive monthly eye injections.Roche’s Susvimo, previously called port delivery…

Read Full Article (External Site)